Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorMULUMBA, B. K.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorLEFFONDRE, Karen
IDREF: 183599128
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMERLE, Benedicte
ORCID: 0000-0003-1332-0954
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorKOROBELNIK, Jean-Francois
ORCID: 0000-0002-4438-9535
IDREF: 028739272
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorHELMER, Catherine
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDELCOURT, Cecile
ORCID: 0000-0002-2099-0481
IDREF: 035105291
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorGREGOIRE, Audrey
ORCID: 0000-0002-1494-5764
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDELYFER, Marie-Noelle
dc.date.accessioned2025-02-06T09:48:01Z
dc.date.available2025-02-06T09:48:01Z
dc.date.issued2024-06-01
dc.date.conference2024-05-05
dc.identifier.issn0146-0404en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/204733
dc.description.abstractEnPurpose : Long-term blood pressure variability (BPV) has emerged as a risk factor for various health problems, including eye diseases. Yet, its role on age-related macular degeneration (AMD) onset remains unknown. This population-based longitudinal cohort study aimed to test the hypothesis that a higher BPV is associated with an increased risk of early or advanced AMD in older adults. Methods : The ALIENOR (Antioxidants, LIpides Essentiels, Nutrition et maladies OculaiRes) study included 963 participants aged 73 years and older from the 3-City study (3C), followed every 2-3 years in Bordeaux, France (2006-2020). We analyzed those who had at least two blood pressure (BP) measurements, and were free of early and/or advanced AMD at baseline, according to the form studied. BP was measured every 2-3 years in 3C (1999-2017). Systolic (SBPV), diastolic (DBPV) and pulse (PPV) BPV were determined by the standard deviation method at each visit and considered as time-dependent variables. AMD was classified using retinal color photographs and optical coherence tomography imaging. After multiple imputation on covariates, shared random effects joint models fitted individual BPV trajectories (longitudinal data) and quantified their effect on AMD onset (survival data). Using the R package JMbayes2, the Bayesian approach yielded mean adjusted Hazard Ratios (aHR) of AMD and their 95% credible intervals (95%CrI). Results : Of 475 and 692 participants analyzed, 36% and 10% developed respectively early and advanced AMD, after a mean follow-up of 8 years. BPV was not associated with an increased risk of early AMD (aHR: 0.95, 95%CrI: 0.81–1.09, p=0.47; aHR: 0.95, 95%CrI: 0.71–1.30, p=0.75; and aHR: 0.90, 95%CrI: 0.75–1.06, p=0.21; for a 5-mmHg increase in SBPV, DBPV and PPV respectively). Conversely, the risk of advanced AMD was significantly 60% higher for a 5-mmHg increase in DBPV (aHR: 1.60, 95%CrI: 1.05–2.43, p=0.03), whereas significance was not reached for a 5-mmHg increase in SBPV (aHR: 1.20, 95%CrI: 0.95–1.52, p=0.12) and PPV (aHR: 1.13, 95%CrI: 0.85–1.49, p=0.39). Complete case analysis revealed similar results. Conclusions : Among BPV components, only higher DBPV was associated with an increased risk of advanced AMD, and none was associated with an increased risk of early AMD. However, replicating the study in other contexts is necessary to confirm these results.
dc.language.isoENen_US
dc.title.enLong-term blood pressure variability and risk of age -related macular degeneration in older adults: the ALIENOR study
dc.typeCommunication dans un congrèsen_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
bordeaux.volume65en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue7en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.conference.title2024 ARVO Annual Meetingen_US
bordeaux.countryusen_US
bordeaux.title.proceedingInvestigative Ophthalmology & Visual Scienceen_US
bordeaux.teamLEHA_BPHen_US
bordeaux.teamBIOSTAT_BPHen_US
bordeaux.conference.citySeattleen_US
hal.identifierhal-04932076
hal.version1
hal.date.transferred2025-02-27T08:59:56Z
hal.proceedingsouien_US
hal.conference.organizerARVOen_US
hal.conference.end2024-05-09
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.date=2024-06-01&rft.volume=65&rft.issue=7&rft.eissn=0146-0404&rft.issn=0146-0404&rft.au=MULUMBA,%20B.%20K.&LEFFONDRE,%20Karen&MERLE,%20Benedicte&KOROBELNIK,%20Jean-Francois&HELMER,%20Catherine&rft.genre=unknown


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record